Heron Bay Capital Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,225
Closed -$227K 101
2023
Q3
$227K Buy
2,225
+215
+11% +$21.8K 0.06% 72
2023
Q2
$203K Buy
+2,010
New +$201K 0.06% 75

Other funds holding NVS

Heron Bay Capital Management's NVS Position: Q4 2023 in Review

Heron Bay Capital Management sold out of Novartis (NVS) in Q4 2023, closing a stake of 2,225 shares — an estimated $227K sold.

Heron Bay Capital Management first reported a position in NVS in Q2 2023 and held it in 2 quarters. The position peaked at $227K in Q3 2023. 1,272 funds tracked by Wall St. Rank hold NVS as of Q4 2023.

  • Heron Bay Capital Management reported no remaining Novartis position as of Q4 2023 after selling out during the quarter.
  • Heron Bay Capital Management sold 2,225 Novartis shares in Q4 2023, an estimated $227K.
  • Heron Bay Capital Management first reported a position in Novartis in Q2 2023 and held it in 2 quarters.
  • Heron Bay Capital Management's Novartis position peaked at $227K in Q3 2023.
  • 1,272 funds tracked by Wall St. Rank held Novartis as of Q4 2023.

Based on Heron Bay Capital Management's 13F filing for Q4 2023, filed 12 Jan 2024.